Every second, an adult generates around five million new blood cells to replace aging or dying ones, making the blood system a highly regenerative organ.

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that ...

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...

Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC ...

Topas Therapeutics today announced the publication of data highlighting the ability of its proprietary antigen-coupled ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.